Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Recurrence 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Leukemia, Myeloid 1Leukemia 1

Interventions

fludarabine 7Tacrolimus 6fludarabine phosphate 5Whole-Body Irradiation 5Cyclophosphamide 5Busulfan 5Peripheral Blood Stem Cell Transplantation 4Mycophenolic Acid 4Methotrexate 4Sirolimus 3Melphalan 3Cytarabine 3Bone Marrow Transplantation 3thymoglobulin 2ponatinib 2Patient Reported Outcome Measures 2Mesna 2Behavior Therapy 2quizartinib 1nicotinamide-beta-riboside 1methanesulfonic acid 1etoposide phosphate 1blinatumomab 1Thiotepa 1Stem Cell Transplantation 1Social Determinants of Health 1RFT5-SMPT-dgA immunotoxin 1Photopheresis 1Panobinostat 1Immunotherapy, Adoptive 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Leukemia, Myeloid × quizartinib × Lymphoid × Clear all
NCT01411267 2022-04-04

AC220 for Children With Relapsed/Refractory ALL or AML

Therapeutic Advances in Childhood Leukemia Consortium

Phase 1 Completed
24 enrolled 14 charts
LymphoidOther hematologic neoplasm

Leukemia, Leukemia, Myeloid, Recurrence, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡